Last10K.com

Greenlight Biosciences Holdings, Pbc (GRNA) SEC Filing S-1 IPO Report

Greenlight Biosciences Holdings, Pbc

CIK: 1822691 Ticker: GRNA

View differences made from one to another to evaluate Greenlight Biosciences Holdings, Pbc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this S-1 Registration of Securities to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Greenlight Biosciences Holdings, Pbc.

Continue

Assess how Greenlight Biosciences Holdings, Pbc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Greenlight Biosciences Holdings, Pbc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this S-1 Registration of Securities

Cover Page
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Stockholders' (Deficit) Equity
Consolidated Statements Of Changes In Stockholders' (Deficit) Equity (Parentheticals)
Consolidated Statements Of Operations
Accrued Expenses
Accrued Expenses (Tables)
Accrued Expenses - Summary Of Accrued Expenses (Detail)
Bayer Asset Acquisition
Bayer Asset Acquisition - Additional Information (Detail)
Business Combination
Business Combination (Tables)
Business Combination - Additional Information (Detail)
Business Combination - Schedule Of Number Of Shares Of Common Stock Outstanding Immediately Consummation Of Business Combination (Details)
Business Combination - Summary Of Reconciles Elements Of Business Combination (Details)
Collaboration Agreement
Collaboration Arrangement - Additional Information (Detail)
Commitments And Contingencies
Commitments And Contingencies (Details)
Commitments And Contingencies (Tables)
Commitments And Contingencies - Summary Of Future Minimum Lease Payments Under Noncancelable Operating Leases (Details)
Commitments And Contingencies - Summary Of Future Minimum Payments Under These Capital Lease Arrangements (Details)
Common Stock
Common Stock (Tables)
Common Stock - Additional Information (Details)
Common Stock - Summary Of Common Stock Reserved For Future Issuance (Details)
Debt
Debt (Tables)
Debt - Additional Information (Detail)
Debt - Summary Of Future Principal Payment Of Long Term Debt (Detail)
Debt - Summary Of Interest Expense (Detail)
Debt - Summary Of Outstanding Debt (Detail)
Debt - Summary Of Outstanding Debt (Parenthetical) (Details)
Defined Contribution Plan
Defined Contribution Plan - Additional Information (Details)
Fair Value Measurements
Fair Value Measurements (Details)
Fair Value Measurements (Details) - Schedule Of Assets And Liabilities At Fair Value On A Recurring Basis
Fair Value Measurements (Details) - Schedule Of Changes In The Fair Value Of Level 3 Warrant Liabilities
Fair Value Measurements (Tables)
Grant Revenue
Grant Revenue - Additional Information (Detail)
Income Taxes
Income Taxes (Details)
Income Taxes (Tables)
Income Taxes - Summary Of Significant Components Of Deferred Tax Assets And Liabilities (Details)
Income Taxes - Summary Of The Reconciliation Of Effective Tax Rate To The Statutory Federal Income Tax Rate (Detail)
License Agreement
License Agreement - Additional Information (Detail)
License And Collaboration Agreement
License And Collaboration Agreement - Additional Information (Detail)
Nature Of Business And Basis Of Presentation
Nature Of Business And Basis Of Presentation (Details)
Net Loss Per Share
Net Loss Per Share (Tables)
Net Loss Per Share - Summary Of The Computation Of Basic And Diluted Net Loss Per Share Attributable To Common Stockholders (Details)
Net Loss Per Share - Summary Of The Excluded Potential Common Stock (Details)
Property And Equipment, Net
Property And Equipment, Net (Tables)
Property And Equipment, Net - Additional Information (Detail)
Property And Equipment, Net - Summary Of Property And Equipment (Detail)
Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock (Tables)
Redeemable Convertible Preferred Stock - Summary Of Temporary Equity (Details)
Redeemable Convertible Preferred Stock - Summary Of Temporary Equity (Parenthetical) (Details)
Redeemable Convertible Preferred Stock- Additional Information (Details)
Stock-Based Compensation
Stock-Based Compensation (Tables)
Stock-Based Compensation - Additional Information (Details)
Stock-Based Compensation - Schedule Of Stock Option Activity (Details)
Stock-Based Compensation - Summary Of Assumptions In The Binomial Option-Pricing Model Used To Determine The Fair Value Of Stock Options (Details)
Stock-Based Compensation - Summary Of Stock Options Activity (Parenthetical) (Details)
Stock-Based Compensation - Summary Of Stock-Based Compensation Expense (Details)
Stock-Based Compensation - Summary Of The Company's Restricted Stock Activity (Details)
Stockholder's Equity (Tables)
Stockholders' Equity
Stockholders' Equity (Details)
Stockholders' Equity - Summary Of Legacy Redeemable Convertible Preferred Stock Authorized, Issued, And Outstanding (Details)
Stockholders' Equity - Summary Of Legacy Redeemable Convertible Preferred Stock Authorized, Issued, And Outstanding (Parenthetical) (Details)
Subsequent Events
Subsequent Events - Additional Information (Detail)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Summary Of Estimated Useful Lives Of Property And Equipment (Detail)
Warrants
Warrants (Details)
Warrants (Tables)
Warrants - Summary Of Common Stock Warrant Classified (Detail)
Warrants - Summary Of Estimated The Fair Value Of The Warrants (Detail)
Warrants - Summary Of Preferred Stock Warrants Classified As Liabilities (Detail)
Warrants - Summary Of Roll-Forward Of The Warrants (Details)
Warrants - Summary Of Roll-Forward Of The Warrants (Parenthetical) (Details)
Ticker: GRNA
CIK: 1822691
Form Type: S-1 Registration of Securities
Accession Number: 0001193125-22-251296
Submitted to the SEC: Mon Sep 26 2022 4:33:19 PM EST
Accepted by the SEC: Mon Sep 26 2022
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/grna/0001193125-22-251296.htm